Announcement of prospectus regarding the admission to trading of new shares in Arcam
(Cision Via Acquire Media NewsEdge) The Board of Directors of Arcam AB (publ) (“Arcam”) has prepared a prospectus regarding the admission to trading of newly issued shares on NASDAQ OMX Stockholm. The prospectus has been approved and registered with the Swedish Financial Supervisory Authority and is now available on Arcam’s website www.arcam.com.
The prospectus has been prepared for the admission to trading of 400,000 new shares, which were placed by Carnegie Investment Bank AB with international institutional investors and qualified investors in Sweden on December 16, 2013.
The newly issued shares are expected to be admitted to trading on NASDAQ OMX Stockholm on or about January 10, 2014 on NASDAQ OMX Stockholm. For further information please contact: Magnus René, CEO Arcam AB Tel: 46 31 710 32 00, alt. cell: 46 702 79 89 99 or E-mail: firstname.lastname@example.org Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam’s market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China.
Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31 -710 32 00 • www.arcam.com
This information was brought to you by Cision http://news.cision.comhttp://news.cision.com/arcam/r/announcement-of-prospectus-regarding-the-admission-to-trading-of-new-shares-in-arcam,c9518812The following files are available for download:http://mb.cision.com/Main/5885/9518812/198430.pdf
(c) 2014 Cision. All Rights Reserved.
[ Back To TMCnet.com's Homepage ]